Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Additionally, an optional 52-week open-label extension was available for women who completed the core study
Semaglutide and Wegovy mimic a hormone that regulates appetite and blood sugar, while Zepbound targets two hormones for potentially greater weight loss
Different patients have different goals, responses, and healthcare needs
I feel your risk of low blood sugar is actually lower when youre taking a GLP-1 because you eventually need less insulin. SGLT-2s increase the risk of DKA and dehydration The biggest challenge to using SGLT-2 inhibitors in type 1 diabetes is the risk for DKA, including a rare type called euglycemic DKA (EDKA)
With continued immune modulation over time.*
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
